Loading stock data…
CLRO
$3.51+0.23 (+7.01%)
Market ClosedLast close May 1
ClearOne, Inc., together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ClearOne, Inc. in the Technology sector is trading at $3.51. The stock is currently near its 52-week low of $2.71, remaining 30.1% below its 200-day moving average. Technical signals show neutral RSI of 60 and bullish MACD crossover, explaining why CLRO maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 60) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
AAPLMSFTGOOGL
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$3.51
Potential Upside
5%
Whystock Fair Value$3.69
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
ClearOne, Inc., together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally. The company offers audio conferenc...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.40M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.18
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
806.16%
Volume
Today's trading volume
2,664
Recent News
The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne
SAP's cloud and AI push, Novartis' strong drug lineup, and Philip Morris' smoke-free growth headline Zacks' latest analyst picks.
Top Stock Reports for SAP, Novartis & Philip Morris
SAP, Novartis and Philip Morris headline today's top Zacks reports, each showing strong momentum and strategic growth drivers despite industry headwinds.
ClearOne Stock Falls on Wider Q2 Loss, Revenue Decline and Sale Plan
CLRO posts a wider Q2 loss on revenue decline, rising costs and supply issues as it pursues an asset sale to address ongoing risks.
The Zacks Analyst Blog Highlights Microsoft, SAP, AMD, PrimeEnergy Resources and ClearOne
MSFT, SAP, and AMD drive tech gains with cloud and AI tailwinds, while PNRG thrives on energy strength and CLRO faces sharp revenue declines.
Top Stock Reports for Microsoft, SAP & AMD
MSFT, SAP, and AMD are driving growth with cloud, AI, and chip innovation despite competitive and cost headwinds.